is whether his medication is present in seminal fluid and can transfer through vaginal mucosa, cross the placenta, and be teratogenic. In fact, post-conception exposure of the embryo or fetus is likely minimal,  as seminal concentrations of medications and volumes transferred are small In the absence of adequate data regarding paternal exposure for most medications used for RMD, we developed recommendation statements when 1) at least some data on paternal exposure were available, 2) accumulated